Amplitude Ventures
Montréal, Québec
Investment Thesis
Amplitude is a dedicated company builder investing in precision medicine and next-generation medical devices at inflection points, partnering with world-class teams to build category-leading Canadian companies with global reach. The fund leverages its pre-Amp venture creation studio, deep industry partnerships, and active board engagement from ideation through value acceleration and exit.
Focus Areas
Investment Stage
SeedGrowth
Sectors
Investment Signals
Check SizeC$5M to C$30M
GeographyCanada-focused
ProvincesQC, ON, AB, BC
RoleLead
Impact MandateYes
Business Modelsdeep-tech, B2B
Sample Portfolio Companies
Evommune (NYSE: EVMN)
Reverb Therapeutics
Tentarix Biotherapeutics
Nomic Bio
Radiant Biotherapeutics
Abdera Therapeutics
Ability Biotherapeutics
Celsius Therapeutics
Congruence
Prilenia
RIME Therapeutics
Management Team
A
Amplitude Investment Team
What Makes Us Unique
Dedicated company builder from ideation to treatment. Pre-Amp venture creation studio. Industry partner leverage.
AUM & Sources
Est. US$340M
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.